Changing Prescribing Behavior of Primary Care Providers (PCPs) to Reduce Risk of Vascular Events (VEs) During Testosterone Replacement Therapy (TRT) By Improving Access Through Electronic Consultation and Incorporating Education on Ordering and Interpreting Testosterone (T) Levels in a Lab Order Set

Introduction: Endocrinologists at this institution have adhered since 2008 to a policy governing who and when to prescribe TRT, akin to Endocrine Society guidelines. The policy, which does not apply to PCPs, excludes patients with a history of VEs (MI/CAD, CVA, VTE, PVD)